Modified Timed Up and Go Test for Tendency to Fall and Balance Assessment in Elderly Patients With Gait Instability

Abstract

Objective: To compare the results from the modified Timed Up and Go Test (TUG) with posturographic variables, the subjective perception of disability due to gait instability, and the number of falls in a sample of the elderly population with imbalance, to confirm that the TUG Test is a useful clinical instrument to assess the tendency to fall in individuals of this age group. Materials and Methods: Cross-sectional study conducted in a tertiary university hospital, in 174 people aged 65 years or older with gait instability. Modified TUG Test was performed; time, step count and the need for support during the test were the analyzed variables. They were compared with the number of falls, Computerized Dynamic Posturography scores, and questionnaires scores (Dizziness Handicap Inventory and a shortened version of the Falls Efficacy Scale-International). Results: The average time to complete the TUG Test was 21.24 ± 8.18 s, and the average step count was 27.36 ± 7.93. One hundred two patients (58.6%) required no support to complete the test, whereas the other 72 (41.4%) used supports. The time taken to complete the Test was significantly related with having or not having fallen in the previous year, with the scores of the questionnaires, and with various parameters of dynamic posturography. A higher percentage of patients who took more than 15 s had fallen in the previous year than those who took up to 15 s to complete the test [P = 0.012; OR = 2.378; 95% CI (1.183, 4.780)]. No significant correlation was found between the step count and the number of falls in the previous year, with falling during the test or not, or with being a single or a frequent faller. No relation was found between the need for supports and the number of falls, with having or not having fallen in the previous year, or with being a single or frequent faller. Soto-Varela et al. TUG and Falls in Elderly Conclusion: The modified TUG Test is in relation with the presence or absence of falls. Time is the essential parameter for analyzing the risk of falling and the 15-s threshold is a good value to differentiate elderly patients at high risk of falling.

High Specificity of Single Inertial Sensor-Supplemented Timed Up and Go Test for Assessing Fall Risk in Elderly Nursing Home Residents

“…The mean was 24.5 s for F and 21.5 s for NF, both values that are close to the 22.5 s found in [ 4 ] and the 22.1 s found in [ 29 ]. Furthermore, the inclusion of kinematic data from a single wearable IMU sensor allowed for computing TUG’s subtask durations.…”

Predicting 30-Day Readmission for Stroke Using Machine Learning Algorithms: A Prospective Cohort Study

“…Second, the analysis was limited to 30-day readmission, which reduces the subset of patients with stroke in which the ANN model is clinically applicable. Third, imbalance between positive and negative outcomes, i.e., class imbalance, is a common problem in analysis of medical data and has not been satisfactorily addressed ( 45 , 46 ). Further studies are needed to investigate the use of ensemble algorithm for solving the class imbalance problem.…”

Prevención de la sarcopenia en pacientes con enfermedad de Parkinson: Revisión descriptiva desde la medicina preventiva

“…La testosterona es una hormona asociada a la fuerza y masa muscular; administrada en dosis bajas aumenta ésta por aumento de la síntesis de proteínas y disminución de la grasa; aumenta el músculo y la fuerza muscular, ya que activa el reclutamiento de células satélite y reduce las células madre adiposas. El temor a los efectos negativos de la testosterona ha impulsado la exploración de moduladores selectivos de los receptores de andrógenos (SARM) que pueden ser, en teoría, más seguros (61,62).…”

“…La grelina se asocia a un aumento en la ingesta de alimentos y a la producción de hormona de crecimiento; mientras que la capromorelina, que funciona como agonista de grelina, aumenta la masa magra, la caminata en tándem y la subida de escaleras en quienes la consumen por mínimo por un año. A pesar de todo esto, ningún otro fármaco en desarrollo ha demostrado ser más eficaz y seguro que la testosterona (61,62).…”

“…/doi.org/10.32776/revbiomed.v32i1.822 y el poder de subir escaleras, pero no la velocidad de la marcha. En general, estudios demuestran que los SARM no son mejor que la testosterona (61). …”